| Title | Dysregulation of N-6-methyladenosine regulators predicts poor patient survival in mantle cell lymphoma |
| Authors | Zhang, Weilong He, Xue Hu, Jing Yang, Ping Liu, Cuiling Wang, Jing An, Ran Zhen, Jingfei Pang, Meng Hu, Kai Ke, Xiaoyan Zhang, Xiuru Jing, Hongmei |
| Affiliation | Peking Univ Third Hosp, Lymphoma Res Ctr, Dept Hematol, 49 Huayuan North Rd, Beijing 100191, Peoples R China Capital Med Univ, Beijing Tiantan Hosp, Dept Pathol, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100191, Peoples R China |
| Keywords | RNA RNA modification N-6-methyladenosine lymphoma |
| Issue Date | 2019 |
| Publisher | ONCOLOGY LETTERS |
| Abstract | N-6-methyladenosine (m(6)A) is the most abundant eukaryote mRNA modification, modulated by regulators known as epigenetic writers, erasers and readers, which are known to serve crucial roles in mRNA metabolism. However, the role of m(6)A during B-cell development and B-cell tumorigenesis remains poorly understood. By analyzing the gene expression profile of 123 mantle cell lymphoma cases from the Gene Expression Omnibus database, the present study demonstrated that one-half of the m(6)A regulators were able to predict patient survival in mantle cell lymphoma, notably the m(6)A.index. The expression levels of the m(6)A regulators were regarded as good classifiers in mantle cell lymphoma. The m(6)A.index-low mantle cell lymphoma type exhibited a poor patient survival and lower mRNA levels from the total transcriptome. The m(6)A regulators may be associated with the cell division and the RNA metabolic pathways, which may result in poor survival of patients with mantle cell lymphoma. |
| URI | http://hdl.handle.net/20.500.11897/544831 |
| ISSN | 1792-1074 |
| DOI | 10.3892/ol.2019.10708 |
| Indexed | SCI(E) EI |
| Appears in Collections: | 第三医院 |
